Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023).
Savulescu C, Prats-Uribe A, Brolin K, Uusküla A, Bergin C, Fleming C, Zvirbulis V, Zavadska D, Szułdrzyński K, Gaio V, Popescu CP, Craiu M, Cisneros M, Latorre-Millán M, Lohur L, McGrath J, Ferguson L, Abolina I, Gravele D, Machado A, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sui J, Kenny C, Krievins D, Barzdina EA, Melo A, Kosa AG, Miron VD, Muñoz-Almagro C, Milagro AM, Bacci S, Kramarz P, Nardone A; VEBIS HCW Study Group. Savulescu C, et al. Among authors: prats uribe a. Vaccine. 2024 Dec 25;45:126615. doi: 10.1016/j.vaccine.2024.126615. Online ahead of print. Vaccine. 2024. PMID: 39724693
Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021-May 2023.
Savulescu C, Prats-Uribe A, Brolin K, Lovrić Makarić Z, Uusküla A, Panagiotakopoulos G, Bergin C, Fleming C, Agodi A, Bonfanti P, Murri R, Zvirbulis V, Zavadska D, Szuldrzynski K, Machado A, Popescu CP, Craiu M, Cisneros M, Latorre-Millán M, Petrović G, Lohur L, Tryfinopoulou K, McGrath J, Ferguson L, Barchitta M, Spolti A, de Gaetano Donati K, Abolina I, Gravele D, Gaio V, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sarajlić G, Amerali M, Sui J, Kenny C, Rapisarda V, Rossi M, Lamonica S, Krievins D, Barzdina EA, Palmira Amaral A, Kosa AG, Miron VD, Muñoz-Almagro C, Milagro AM, Bacci S, Kramarz P, Nardone A, The Vebis Hcw Ve Study Group. Savulescu C, et al. Among authors: prats uribe a. Vaccines (Basel). 2024 Nov 19;12(11):1295. doi: 10.3390/vaccines12111295. Vaccines (Basel). 2024. PMID: 39591197 Free PMC article.
Standardised and Reproducible Phenotyping Using Distributed Analytics and Tools in the Data Analysis and Real World Interrogation Network (DARWIN EU).
Dernie F, Corby G, Robinson A, Bezer J, Mercade-Besora N, Griffier R, Verdy G, Leis A, Ramirez-Anguita JM, Mayer MA, Brash JT, Seager S, Parry R, Jodicke A, Duarte-Salles T, Rijnbeek PR, Verhamme K, Pacurariu A, Morales D, Pinheiro L, Prieto-Alhambra D, Prats-Uribe A. Dernie F, et al. Among authors: prats uribe a. Pharmacoepidemiol Drug Saf. 2024 Nov;33(11):e70042. doi: 10.1002/pds.70042. Pharmacoepidemiol Drug Saf. 2024. PMID: 39532529
Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24.
Savulescu C, Prats-Uribe A, Brolin K, Uusküla A, Bergin C, Fleming C, Murri R, Zvirbulis V, Zavadska D, Gaio V, Popescu CP, Hrisca R, Cisneros M, Latorre-Millán M, Lohur L, McGrath J, Ferguson L, De Gaetano Donati K, Abolina I, Gravele D, Machado A, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sui J, Kenny C, Santangelo R, Krievins D, Barzdina EA, Valadas Henriques C, Kosa AG, Pohrib SM, Muñoz-Almagro C, Milagro A, Bacci S, Nardone A; VEBIS HCW VE study group; Collaborators in VEBIS HCW study group. Savulescu C, et al. Among authors: prats uribe a. Euro Surveill. 2024 Oct;29(44):2400680. doi: 10.2807/1560-7917.ES.2024.29.44.2400680. Euro Surveill. 2024. PMID: 39484687 Free PMC article.
Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones.
Guo Y, Raventós B, Català M, Elhussein L, López-Güell K, Tan EH, Prats-Uribe A, Dedman D, Man WY, Omulo H, Delmestri A, Lane JCE, Rahman U, Griffin XL, Gao C, Cole C, Batty P, Connelly J, Booth H, Cave A, Donegan K, Prieto-Alhambra D, Burn E, Jödicke AM. Guo Y, et al. Among authors: prats uribe a. Pharmacoepidemiol Drug Saf. 2024 Oct;33(10):e70022. doi: 10.1002/pds.70022. Pharmacoepidemiol Drug Saf. 2024. PMID: 39414581
Treatment of systemic lupus erythematosus: Analysis of treatment patterns in adult and paediatric patients across four European countries.
Du M, Dernie F, Català M, Delmestri A, Man WY, Brash JT, van Ballegooijen H, Mercadé-Besora N, Duarte-Salles T, Mayer MA, Leis A, Ramírez-Anguita JM, Griffier R, Verdy G, Prats-Uribe A, Pacurariu A, Morales DR, De Lisa R, Galluzzo S, Egger GF, Prieto-Alhambra D, Tan EH. Du M, et al. Among authors: prats uribe a. Eur J Intern Med. 2024 Dec;130:106-117. doi: 10.1016/j.ejim.2024.08.008. Epub 2024 Aug 11. Eur J Intern Med. 2024. PMID: 39134452 Free article.
Reverse total shoulder replacement versus anatomical total shoulder replacement for osteoarthritis: population based cohort study using data from the National Joint Registry and Hospital Episode Statistics for England.
Valsamis EM, Prats-Uribe A, Koblbauer I, Cole S, Sayers A, Whitehouse MR, Coward G, Collins GS, Pinedo-Villanueva R, Prieto-Alhambra D, Rees JL. Valsamis EM, et al. Among authors: prats uribe a. BMJ. 2024 Apr 30;385:e077939. doi: 10.1136/bmj-2023-077939. BMJ. 2024. PMID: 38688550 Free PMC article.
71 results